Project Details
| Status | Active |
|---|---|
| Effective start/end date | 04/7/16 → … |
A Phase III, randomised, double blind, placebo-controlled, parallel group, efficacy, safety and tolerability trial of once daily, oral doses of Empagliflozin as Adjunctive to inSulin
Project: Research